Description
In this fourth issue of the CPD Bulletin in Cellular Pathology I am able to report a considerable amount of formal and informal positive feedback, both for the Bulletin and for the Study Days, which have run in association with each issue of the Bulletin. We are delighted that the CPD Bulletin is approved by the Royal College of Pathologists, and we are pleased to have an excellent Leader from Clair du Boulay on the transition from CME to CPD within this issue.
The Bulletin is from now on to become a subscription based Journal and for 45 per annum there will be three issues with free MCQ participation. It is interesting to note that in the current climate of increasing requirements for CPD, several trusts are known to be paying for items such as the CPD journals for individual consultants. Were always interested to hear of potential advertisers for the CPD Bulletin and would usually like to devote one page to an advertisement but there may be room for more. We should also welcome from participants ideas on topics for future CPD Bulletins, when we have covered the gamut of the body systems and special areas in Cellular Pathology. We would also welcome any views on the format of the bulletin and the format of the Study Days.
We have so far conducted all the Study Days in London at a variety of venues depending on the number of registrants. It is interesting to note, that of the last 100 attendees 42% were from north of Birmingham. We would be happy to run a Study Day further north but realise that London is probably the easiest place in the country for most people to get to for a one day meeting. We would indeed value the thoughts of Study Day participants on this and if enough people were to suggest that they might like a northern Study Day perhaps once a year, or once as a trial, we would be happy to arrange this.
To turn to the content of the current issue I have already mentioned the excellent leader from Clair du Boulay, this is followed by an explanatory letter from Georgina DaCambra on the future pricing of the bulletin. We then have an excellent series of articles on the use, the practicalities and problems of immunocytochemistry. Keith Miller, a well recognised expert in the techniques of immunohistochemistry, gives us some excellent practical tips and Susan Van Noorden tells us how to use control tissues properly for useful immunocytochemistry. Gillian Williams tackles the common problem of the unknown primary with clarity and helpful tables, which I’m sure we will all stick on the wall in front of our microscope. Joseph Geradts gives some important pointers on prognosis via immunohistochemistry techniques. Andrew Nicholson concentrates on the difficult problem of using immunohistochemistry for unravelling difficult pleural tumours. There is then a pair of articles by John Burtham, from Kevin Gatters unit, on the role of immunohistochemistry in haematopathology and low grade B cell lymphomas are reviewed by Andrew Wotherspoon who is an expert in this disease. Finally, our Editor, Sanjiv Manek, has produced a very clear practical article on the use of immunocytochemistry in gynaecological diseases, in particular the application of immunocytochemistry to some less well known but extremely important uses of cytology in gynaecological practice. We are very grateful for the excellent help, advice and experience of Ashley Price in the preparation of this issue of the Bulletin. I hope you will enjoy reading this bulletin as much as I have and that you consider taking out a subscription, complete the MCQs and participate actively in the Study Days.
